85 related articles for article (PubMed ID: 8091651)
1. The spread of a replication-competent MuLV retroviral vector can be efficiently blocked by deletion variants.
Nouvel P; Panthier JJ; Condamine H
Virology; 1994 Oct; 204(1):180-9. PubMed ID: 8091651
[TBL] [Abstract][Full Text] [Related]
2. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes.
Hill SA; Shuh M; Derse D
Virology; 1999 Oct; 263(2):273-81. PubMed ID: 10544101
[TBL] [Abstract][Full Text] [Related]
4. Virofection: a one-step procedure for using replication-defective retrovirus vectors.
Flamant F; Samarut J
Virology; 1995 Aug; 211(1):234-40. PubMed ID: 7645216
[TBL] [Abstract][Full Text] [Related]
5. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line.
Ronfort C; Girod A; Cosset FL; Legras C; Nigon VM; Chebloune Y; Verdier G
Virology; 1995 Feb; 207(1):271-5. PubMed ID: 7871738
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer in bovine blastocysts using replication-defective retroviral vectors packaged with Gibbon ape leukemia virus envelopes.
Kim T; Leibfried-Rutledge ML; First NL
Mol Reprod Dev; 1993 Jun; 35(2):105-13. PubMed ID: 8391277
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
Girod A; Cosset FL; Verdier G; Ronfort C
Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301
[TBL] [Abstract][Full Text] [Related]
9. A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus.
Boerkoel CF; Federspiel MJ; Salter DW; Payne W; Crittenden LB; Kung HJ; Hughes SH
Virology; 1993 Aug; 195(2):669-79. PubMed ID: 8393241
[TBL] [Abstract][Full Text] [Related]
10. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
11. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
Warden MP; Weir JP
Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
[TBL] [Abstract][Full Text] [Related]
12. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
13. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
Torrent C; Wang P; Darlix JL
Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
[TBL] [Abstract][Full Text] [Related]
14. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
15. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
Federspiel MJ; Hughes SH
Virology; 1994 Sep; 203(2):211-20. PubMed ID: 8053145
[TBL] [Abstract][Full Text] [Related]
16. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
Chakraborty AK; Zink MA; Hodgson CP
Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
[TBL] [Abstract][Full Text] [Related]
18. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
19. Recombinant equine arteritis virus as an expression vector.
de Vries AA; Glaser AL; Raamsman MJ; Rottier PJ
Virology; 2001 Jun; 284(2):259-76. PubMed ID: 11384225
[TBL] [Abstract][Full Text] [Related]
20. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
Curran MA; Kaiser SM; Achacoso PL; Nolan GP
Mol Ther; 2000 Jan; 1(1):31-8. PubMed ID: 10933909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
